Stock Financial Ratios, Dividends, Split History

BCEI / Bonanza Creek Energy, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price35.17
Volume173,100.00
Market Cap ($M)725.17
Enterprise Value ($M)739.13
Book Value ($M)703.21
Book Value / Share34.31
Price / Book1.04
NCAV ($M)-110.71
NCAV / Share-5.40
Price / NCAV-6.59
Share Statistics
Common Shares Outstanding 20,453,619
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)n/a
Return on Assets (ROA)n/a
Return on Equity (ROE)n/a
Balance Sheet (mrq) ($M)
Assets872.41
Liabilities169.19
Quick Ratio0.55
Current Ratio0.57
Income Statement (mra) ($M)
Oil And Gas Sales Revenue0.00
Cash Flow Statement (mra) ($M)
Identifiers and Descriptors
CUSIP097793103
Central Index Key (CIK)1509589
Related CUSIPS
097793400 097793900 097793903 097793950 097793953

Split History

Stock splits are used by Bonanza Creek Energy, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Should Bonanza Creek Energy (BCEI) Be On Your Radar Now?

2018-07-13 zacks
It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though there are some hidden gems that could be worth uncovering by those with a high risk tolerance. One way to find these underappreciated stocks is by looking at companies that haven’t seen their share prices move higher lately, but have observed analysts raising earnings estimates for their stock.

The Zacks Analyst Blog Highlights: Bonanza Creek Energy, Cleveland-Cliffs, Foundation Building Materials, Manitowoc and Mellanox Technologies

2018-07-13 zacks
Chicago, IL – July 13, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bonanza Creek Energy, Inc. (BCEI - Free Report) , Cleveland-Cliffs Inc. (CLF - Free Report) , Foundation Building Materials, Inc. (FBM - Free Report) , The Manitowoc Company, Inc. (14-0)

Bonanza Creek Energy, Yum China Holdings, Workday, Adobe Systems and Progress Software highlighted as Zacks Bull and Bear of the Day

2018-07-12 zacks
Chicago, IL – July 12, 2018 – Zacks Equity Research highlights Bonanza Creek Energy, Inc. (BCEI - Free Report) as the Bull of the Day, Yum China Holdings, Inc. (YUMC - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Workday, Inc. (WDAY - Free Report) , Adobe Systems Inc. (ADBE - Free Report) and Progress Software Corp. (PRGS - Free Report) . (28-0)

Q2 Likely to Show Strongest Earnings Since 2010: Top 6 Picks

2018-07-12 zacks
Second-quarter earnings season has commenced, which means investors are closely watching how corporate America performed in the three months ended June. The outcome seems to be quite encouraging, as U.S. companies are expected to see one of the strongest quarterly earnings season in almost a decade. (2-0)

Bull of the Day: Bonanza Creek (BCEI)

2018-07-12 zacks
Bonanza Creek Energy, Inc. (BCEI - Free Report) is cashing in on higher crude prices and strong demand. This Zacks Rank #1 (Strong Buy) is expected to see earnings jump nearly 300% in 2018. Bonanza Creek is a small cap exploration and production company headquartered in Denver, Colorado. With a market cap of $720 million, it has operations in the Wattenberg Field in Colorado and the Cotton Valley sands of Southern Arkansas in the Mid-Continent.

CUSIP: 097793103